Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden.
Autor: | Nguyen, Huy Tram1 (AUTHOR), Nguyen, Nhung1 (AUTHOR), Liu, Liang Yen1 (AUTHOR), Dovek, Laura1 (AUTHOR), Lenchner, Daniel1 (AUTHOR), Harris, Robert2 (AUTHOR), Ozer, Byram1 (AUTHOR), Ravelo, Arliene3 (AUTHOR), Sommer, Nicolas3 (AUTHOR), Sim, Myung Shin4 (AUTHOR), Elashoff, Robert4 (AUTHOR), Green, Richard5 (AUTHOR), Nghiemphu, Phioanh Leia1 (AUTHOR), Cloughesy, Timothy Francis1 (AUTHOR), Ellingson, Benjamin2 (AUTHOR), Lai, Albert1 (AUTHOR) albertlai@mednet.ucla.edu |
---|---|
Zdroj: | Neuro-Oncology Practice. Apr2019, Vol. 6 Issue 2, p103-111. 9p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |